Atrial fibrillation
Conditions
Interventions
Probiotic intervention group:3g/d of Tongrentang probiotic powder (4.0×1010CFU containing L. hamnosus, L. Ruteri and other probiotics) was taken in the first two months after operation.
Control group:None
Sponsors
West China Hospital of Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Patients with atrial fibrillation scheduled for pulmonary vein isolation. (2) The age is greater than or equal to 18 years old and less than or equal to 80 years old. (3) Informed consent was signed voluntarily.
Exclusion criteria
Exclusion criteria: (1) Patients with severe structural heart disease (including valvular heart disease, myocardial infarction, hypertrophic obstructive cardiomyopathy, congenital heart disease, etc.). (2) Advanced heart failure patients with left ventricular ejection fraction 3.0mg/dL). (5) Patients with advanced malignant tumors. (6) Patients with severe complications such as pulmonary fibrosis, liver fibrosis and connective tissue diseases. (7) Patients with hyperthyroidism. (8) Patients older than 80 years old. (9) Taking other probiotic products within the past 15 days
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recurrent rate;Gut microbiota;Serum metabolomic; | — |
Countries
China
Contacts
Public ContactKaijun Cui
West China Hospital, Sichuan University
Outcome results
None listed